About Akero Therapeutics

Website
Website
Employees
Employees
11-50 employees View all
Industry
Industry
Biotechnology
Location
Location
601 Gateway Blvd, Suite 350, South San Francisco, California 94080, US
Description
Information
Akero Therapeutics is a clinical-stage cardio-metabolic company developing transformational treatments for non-alcoholic steatohepatitis (NASH), a disease without any approved therapies. Akero's lead product candidate, efruxifermin (EFX), an engineered Fc-FGF21 fusion protein, is currently being evaluated in a Phase 2b clinical trial as a potential treatment for NASH. Akero is headquartered in South San Francisco.

Akero Therapeutics Alternatives

Industry
biotechnology
Industry
biotechnology
Industry
Biotechnology

Frequently Asked Questions about Akero Therapeutics

What is Akero Therapeutics email format?

The widely used Akero Therapeutics email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.


What is Akero Therapeutics customer service number?

To contact Akero Therapeutics customer service number call here (650) 487-6488. To contact Akero Therapeutics customer service number in your country click here to find.


Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more